0.31%QQQQ 43.45 
0.48%XLF 21.74 3.62%
Digg
Del.icio.us
Newsvine 
Facebook
Stumbleupon
PITTSBURGH - Mylan Inc. said Monday the Food and Drug Administration approved the company's application to sell generic capsules of Sonata, an insomnia treatment.
The company will immediately begin shipping Zaleplon capsules in 5 and 10 mg doses.
Sonata capsules are manufactured by Bristol, Tenn.-based King Pharmaceuticals Inc. The brand-name drug had sales of about $88 million in the year ended in March, according to IMS Health.
Mylan shares declined 2 cents to $12.72 in midday trading.
The above adage is well known by precious-metals investors; in fact I used this quote in one of our monthly reports. I recall how many inquiries ...
Suddenly, drilling for oil is hot. Stickers bearing the slogan "Drill Alaska. Dr...
IN THE HEADLINES McCain caps GOP convention vowing 'change is coming' to Washing...
|
Professional Website Design For Corporate - Get a Free Quote Today
Partners  
|
© 2008 The Ibtimes Company. All Rights Reserved. Terms of service | Privacy Policy | Advertising | About Us | Contact Us | Archives
EMAIL
PRINT
RSS
SHARE
-0.34
0.19
